← Human Trials & Peer-Reviewed Studies
[Protein supplement consumption and its possible association with kidney damage in Mexican elite athletes].
Plain-language guide to PMID 26820197 (2017): observational study of Dietary Proteins.
Key Facts
- PMID
- 26820197
- Journal
- Revista medica del Instituto Mexicano del Seguro Social
- Year
- 2017
- Study type
- Observational Study
- Authors
- Pomerantz A et al. (6 authors)
What This Study Did, in Plain Language
What Was Tested
This observational study looks at Dietary Proteins.
The objective of this study is to analyze the effects of the consumption of protein supplements in the renal function of elite athletes of the Mexican Olympic Training Center.
Why It Was Studied
Protein supplements are one of the most used ergogenic supplements by elite athletes.
Nonetheless, it has been postulated that the use of these type of supplements may cause chronic renal failure.
Who Took Part
By PubMed's age tags, the people studied were young adults and adults, both men and women.
Those that were not excluded were divided into two groups: the experimental group, which included those individuals that had the antecedent of consuming protein supplements, and the control group, that encompassed those individuals that did not had the antecedent of consuming protein supplements.
How the Study Was Run
74 athletes provided urine samples in order to quantify urinary proteins.
Some of them were excluded since they had conditions that could cause proteinuria or alter the quality of the samples.
What Was Measured
Topics PubMed links to this paper include Athletes, Cross-Sectional Studies, Dietary Proteins, Dietary Supplements, Mexico, Performance-Enhancing Substances and Proteinuria.
The authors tagged it with the keywords Adverse effects, Protein supplements and Renal insufficiency.
What This Means in Plain Language
This is an observational study of Dietary Proteins.
The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2017 (Revista medica del Instituto Mexicano del Seguro Social), a journal based in Mexico.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.